99278621 - AMPA PROGRAM

Information

• Trademark
• 99278621

• Source

• Serial Number

  99278621

• International Classifications

  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  July 11, 2025
  3 months ago

• Transaction Date

  July 12, 2025
  3 months ago

• Status Date

  July 11, 2025
  3 months ago

• Status Code

  630

• Attorney Docket Number

  NEUB 2509818

  Attorney Name

  Allison Strickland Ricketts

• Owners

  • Neurocrine Biosciences, Inc.

Case File Statements

• DM0000: The mark consists of an open circle in pink from which extend six lines ending in filled circles. Three of the lines and circles are blue and three are pink. Below that appears the words AMPA, in dark navy blue, which is stacked on top of the word PROGRAM, also in dark navy blue.
• CC0000: The color(s) pink, blue, and dark navy blue is/are claimed as a feature of the mark.
• GS0441: Providing medical information; providing medical information relating to therapies and treatments for anhedonia, major depressive disorder and mood disorders
• GS0421: Pharmaceutical research and development services; conducting clinical trials for pharmaceutical preparations; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results; pharmaceutical research and development services in the field of anhedonia, major depressive disorder and mood disorders; conducting clinical trials for others for pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders; pharmaceutical research services and pharmaceutical product evaluation, namely, conducting post-authorization research for the marketing of pharmaceutical preparations for the treatment and prevention of anhedonia, major depressive disorder and mood disorders, and evaluating epidemiological results for treatments for anhedonia, major depressive disorder and mood disorders; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials; providing medical and scientific research information to patients and practitioners in the field of clinical trials, namely, as to the results of clinical trials pertaining to therapies and treatments for anhedonia, major depressive disorder and mood disorders

Case File Event Statements

• 7/11/2025 - 3 months ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 7/11/2025 - 3 months ago

  2 - APPLICATION FILING RECEIPT MAILED Type: MAFR